APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 281 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $72,500 | -99.9% | 100,000 | -87.7% | 0.00% | -99.9% |
Q2 2023 | $73,976,570 | +102.0% | 812,037 | +46.2% | 2.14% | +97.9% |
Q1 2023 | $36,630,490 | +46.4% | 555,344 | +51.6% | 1.08% | +49.0% |
Q3 2022 | $25,025,000 | +72.2% | 366,400 | +14.0% | 0.73% | +59.6% |
Q2 2022 | $14,529,000 | -80.7% | 321,300 | -78.3% | 0.46% | -69.8% |
Q1 2022 | $75,285,000 | -45.2% | 1,481,700 | -49.0% | 1.51% | +42.4% |
Q4 2021 | $137,272,000 | +577.2% | 2,903,400 | +372.1% | 1.06% | +260.2% |
Q3 2021 | $20,270,000 | -75.7% | 615,000 | -53.5% | 0.29% | -45.9% |
Q2 2021 | $83,570,000 | +22304.8% | 1,322,324 | +11481.0% | 0.54% | +8950.0% |
Q2 2020 | $373,000 | +14.1% | 11,418 | 0.0% | 0.01% | -33.3% |
Q1 2020 | $327,000 | – | 11,418 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |